Douglas G. Cheung
Abstract 1850: CDK inhibitor PHA-848125 preferentially inhibits proliferation of triple negative breast cancer and synergizes with cisplatin
Cheung, Douglas G.; Buzzetti, Marta; Croce, Carlo M.; Leva, Gianpiero di
Citation
Cheung, D. G., Buzzetti, M., Croce, C. M., & Leva, G. D. (2018). Abstract 1850: CDK inhibitor PHA-848125 preferentially inhibits proliferation of triple negative breast cancer and synergizes with cisplatin. Cancer Research, 78(13_Supplement), 1850-1850. https://doi.org/10.1158/1538-7445.am2018-1850
| Journal Article Type | Article |
|---|---|
| Publication Date | Jul 1, 2018 |
| Deposit Date | Jun 14, 2023 |
| Journal | Cancer Research |
| Print ISSN | 0008-5472 |
| Electronic ISSN | 1538-7445 |
| Publisher | American Association for Cancer Research |
| Peer Reviewed | Peer Reviewed |
| Volume | 78 |
| Issue | 13_Supplement |
| Pages | 1850-1850 |
| DOI | https://doi.org/10.1158/1538-7445.am2018-1850 |
| Keywords | Cancer Research; Oncology |
You might also like
Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature.
(2023)
Journal Article
A KRAS-responsive long non-coding RNA controls microRNA processing
(2021)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search